The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes.
about
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatinCE of inorganic species--a review of methodological advancements over 2009-2010.Capillary electrophoretic methods in the development of metal-based therapeutics and diagnostics: new methodology and applications.Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Twenty-one years of microemulsion electrokinetic chromatography (1991-2012): a powerful analytical tool.Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.Cobalt complexes as internal standards for capillary zone electrophoresis-mass spectrometry studies in biological inorganic chemistry.Surfactant-free microemulsion electrokinetic chromatography (SF-MEEKC) with UV and MS detection - a novel approach for the separation and ESI-MS detection of neutral compounds.Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.Antineoplastic drugs and their analysis: a state of the art review.Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates.Enhanced separation of Compound Xueshuantong capsule using functionalized carbon nanotubes with cationic surfactant solutions in MEEKC.Microemulsion Electrokinetic Chromatography.A high-sensitivity LIF detector with silver mirror coating detection window and small-angle optical deflection from collinear system for CE.
P2860
Q34028040-BF9C94B1-77F7-441D-AD1C-EC26B76D484EQ37962884-ABACE958-B8E0-49FE-9702-03D7E2C09C14Q37997361-F9C47A0B-4CB7-463F-A0F4-1FE3AEDA173DQ38000483-25E7EF1F-C1DD-45FF-B4AA-C2EB070250BCQ38052406-6D34E45F-CD94-40BE-979D-8F9B18E5D541Q38086808-AD4CBD1C-CF6A-440D-AE3B-FD5F5AFBDB41Q38886580-012CE2F8-ECB2-43F8-B9FD-2A82BEA291C8Q39043682-3DB99B61-7599-4761-9DF4-3C5BCCE558DFQ39171355-928AD322-8214-452F-8EBC-5BF1CC357204Q39278942-85697B25-183B-40C0-8F67-39A60BE353CAQ39298980-37FACF66-FFB3-43E7-BD7E-F6CE3702E141Q39339684-3830AB27-7641-49B5-9A87-B8B9A06F7215Q39405544-6C86F2EE-862A-4DBD-9253-A4F51D8FF45DQ45964995-055E6B53-D6C2-4763-A325-35B0D828DFF9Q46487766-1348B949-C00E-4D68-ABB0-14E05E2BDFD3Q54784951-64755978-1701-4BF7-AE7E-AAE4C2D3EB34
P2860
The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The first example of MEEKC-ICP ...... anticancer platinum complexes.
@en
type
label
The first example of MEEKC-ICP ...... anticancer platinum complexes.
@en
prefLabel
The first example of MEEKC-ICP ...... anticancer platinum complexes.
@en
P2860
P50
P356
P1433
P1476
The first example of MEEKC-ICP ...... anticancer platinum complexes.
@en
P2093
Anna K Bytzek
Markus Galanski
P2860
P304
P356
10.1002/ELPS.200900522
P577
2010-04-01T00:00:00Z